SCHEMBL14459690

SCHEMBL14459690

CCC(C)(CC)C1CCCN(Cc2ccccc2)C1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.51
▸ BCHE P06276 2/20 0.48
▸ ACHE P22303 3/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ABL1 P00519 1/20 0.45
▸ RIN1 Q13671 1/20 0.45
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ KAT2B Q92831 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13930819 0.91 ACHE (0.53) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL12385776 0.87 CYP2D6 (0.60) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL22623856 0.87 CYP2D6 (0.60) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL19223406 0.87 CYP2D6 (0.60) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL13881892 0.84 ALDH1A1 (0.61) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL13821448 0.82 ACHE (0.60) BCHEACHEABL1RIN1
SCHEMBL14093043 0.77 ACHE (0.57) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL12384396 0.77 ACHE (0.57) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL803463 0.77 CYP2D6 (0.59) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21393195 0.76 CYP2D6 (0.62) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244738-B2 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC (US) 2007-07-17 — — US disclosed
US-7244738-B2 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC (US) 2007-07-17 — — US disclosed
Send feedback